|
KMID : 1141720160040010001
|
|
폐쇄성폐질환
2016 Volume.4 No. 1 p.1 ~ p.1
|
|
|
|
|
Koo Hyun-Kyung
|
|
|
Abstract
|
|
|
|
Asthma is a prevalent disease, and it can cause serious attack and even death. The treatment strategy for asthma still needs effective controller, considering number of asthma patients do not achieve asthma control status. The role of long acting muscarinic antagonist (LAMA) had been evaluated in asthma treatment by several trials. These studies confirmed, tiotropium consistently enhances lung function and peak expiratory flow rate in uncontrolled asthma without serious adverse events. Efficacy of tiotropium for asthma control is optimally expected.
|
|
|
KEYWORD
|
|
|
Asthma, Long acting muscarinic antagonist, Respiratory function
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|